WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

A new device designed to be used as a part of a programme to combat Androgenic Alopecia in clients visiting hair loss clinics or doctors’ offices has been cleared by the Food and Drug Administration in America.

Free-standing LLT device

The Freestanding Capillus272 OfficePro LLLT DeviceThe Capillus 272 OfficePro is a free-standing variation on existing Low Level Laser Therapy (LLLT) devices. It follows on from the Miami-based company’s Capillus 272 cap device, which is designed to be used at home.

According to Capillus, its OfficePro has shown ‘the capability to increase hair growth by improving circulation and cellular metabolism in and around hair follicles’ in a matter of weeks. Furthermore, for the test subjects, the level of ‘patient confidence and scalp health’ is also said to have improved over time.

This type of laser therapy is becoming increasingly popular for both men and women with genetic hair loss – more commonly known as Male Pattern Baldness or Female Pattern Hair Loss.

Many new products have been developed in this area recently, including helmet-styles like the iGrow and the Theradome which emit LLLT directly through the hair to the scalp. This works by increasing circulation and boosting cellular metabolism in the scalp, in order to boost hair growth.

However, the original, award-winning HairMax LaserComb holds an additional patent in relation to its combing technique, which allows the laser’s rays easier, more direct access to the scalp, rather than just the hair.

Although LLLT will not treat hairloss on its own, it can prove a beneficial regrowth boosting companion to clinically-proven hair loss treatment courses by helping the topical treatment minoxidil to circulate effectively.

Builds relationship between hair loss specialist and client

Clinical Therapy Treatment Can Help to Build the Relationship Between Client and Hair Loss SpecialistGiven other efficient LLLT products already exist, including ones which can be used both in-clinic and at-home by clients, what prompted the company to develop this latest medical device?

Capillus says in a press statement that offering an LLLT hair therapy product specifically for use in hair loss clinics or other treatment centres was particularly constructive as it can ‘help physicians guide men and women along their journey to a fuller head of natural hair’.

Carlos Piña, Capillus CEO, explains: “Physicians love the OfficePro because it introduces patients to laser hair therapy in the office… It is a wonderful tool for physicians to build a relationship with patients while administering treatment and monitoring results.”

Having a one-to-one session with a hair loss specialist is undeniably a valuable experience for anyone concerned about thinning hair; indeed, LLLT plays a pivotal role in some of Belgravia’s clinical therapy treatment sessions. This intimate service allows trust to build between the client and the advisor, and also allows for any issues to be addressed straight away. From advice about using treatments or hair washing, to tweaking treatment course components to ensure clients are always on the most effective and suitable courses at any given time, particularly as their lifestyle changes, it can be a huge relief for clients to have someone to talk to about their concerns.

About FDA clearance for LLLT devices

Capillus was granted a 510(k) clearance by the FDA for its 272 OfficePro model. This relates to the safety and effectiveness of new medical devices and FDA clearance must be obtained before they are introduced to the market.

The HairMax LaserComb is also FDA cleared for use by both men and women, and these are provided free of charge to Belgravia clients when they purchase annual treatment plans.

The company’s medical director, Dr. Shelly Friedman, said of the news:“The clearance substantiates what we have known and experienced clinically“. Referring to a recent independently reviewed study of the Capillus272 laser cap which reportedly found an increase of 51% in the hair counts of male and female test subjects, she added: “Capillus is very successful in converting fine, vellus hairs to normal growing hairs.”

For more information on at-home or in-clinic LLLT hair growth boosters, please contact the clinic on 020 7730 6666 or send us a message.


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

MHRA Medical License  X  |   FDA Approval  X  |   Food Supplement  X

Pharmaceutical company Cellmid Limited has produced a new hair loss product called évolis ONE which has shown promising results in an independently tested, blinded, placebo-controlled clinical study.

The spray-on product is designed to treat genetic hair loss in both men and women with minimal side effects and has various patents pending in connection with its formula.

First clinically-validated FGF5 inhibitor hair growth product

Evolis Tonics - Hair Loss ProductsAccording to reports on the B3C newswire and the évolis website, there have been ‘strong positive results in all measured areas of its independently conducted, randomized, blinded and placebo controlled human clinical study of the évolis ONE formulation’.

The product is made in Australia and took 12 years to develop. It is said to have demonstrated ‘efficacy in reducing hair loss, increasing hair growth and improving hair recovery and release’ during the trials, which were carried out by an independent CRO in New York (AMA Laboratories, INC) that specialises in dermatological product testing.

These results make Cellmid Limited, through its subsidiary Advangen Limited, the first company to introduce a clinically-validated FGF5 inhibitor hair growth product to the market in the form of its’ tonics.

The évolis tonics – one for men and one for women – are topical formulas which the website claims ‘May benefit in reducing hair loss, leading to the appearance of thicker hair’. They feature botanical extracts including poterium officinale, rosa multiflora, eriobotrya japonica, ginkgo biloba and swertia chirata.

For best results, users are advised to apply three-to-five sprays of the tonic twice daily – once in the morning then again in the evening. It should be massaged into the affected areas after shampooing, and the hair can be wet or dry during application.

The manufacturers advise users ‘will need to use évolis for a minimum of 16 weeks, twice per day every day’ in order to see results. Continued use of évolis is also recommended to maintain any results obtained, as is complimenting the tonic with shampoos from the range which also contain botanical extracts, as well as a ‘unique Catch and Release polymer to assist with volumising’.

What is FGF5?

FGF5, or ‘Fibroblast growth factor 5′ is a naturally occurring protein found in the body that is programmed by the FGF gene. It speeds up the hair growth cycle and determines hair length.

Restraining FGF5 has been found to extend the Anagen (growth) stage of the hair growth cycle in mammals, including cats and mice, producing long hair. As it also impacts the human hair cycle it is of significant interest to scientists researching hair loss treatments and cures.

The  Nishinihon Journal of Dermatology published a paper entitled ‘ “Sanguisorba Officinalis Root Extract Has FGF-5 Inhibitory Activity and Reduces Hair Loss by Causing Prolongation of the Anagen Period” in 2007. Since then many companies have tried to harness FGF5 to produce the next generation of treatments for Male Pattern Baldness and Female Hair Loss.

Whilst inhibiting FGF5 can help to prolong the hair growth phase, an excess of FGF5 has the opposite effect, leading to the hair prematurely entering the Telogen, or ‘resting’ phase, causing hair to fall out.

Results of clinical trials

Objective, independent clinical trials of évolis ONE were carried out on 32 otherwise healthy individuals, aged between 31 and 55, with androgenetic alopecia.

Men taking part measured between 2 and 4 on the Norwood scale, whilst female subjects registered I-2 to II-2 on the Ludwig scale of hair loss. The trials lasted 112 days (16 weeks) and products were applied twice daily.

Gravimetric Determination methods were used to analyse the impact of évolis ONE in reducing genetic hair loss over 112 days (16 weeks) with twice daily use. Findings showed this resulted in an 80.2% reduction in hair loss.

When testing the ‘hair differentiation’ – the ratio of growing (anagen) hairs to resting (telogen) hair follicles – results gathered based on the Van Scott “hair pluck” method found an anagen increase of 44.2% over the same period .

PhotoGrammetrix™3 measurements, a form of visual assessment using scientific photographs, used to gauge the general improvement in hair quality and volume showed an increase of 143.3%. This visual evaluation was reportedly conducted by AMA’s Institutional Review Board.

A 51 subject Repeat Insult Patch Test (RIPT) exploring skin irritation and sensitisation was also carried out by AMA Laboratories and was said to result in a “zero adverse event” report. However, évolis warns users that those ‘who suffer from a skin condition such as eczema, psoriasis or sensitive skin may experience irritation and/or a dry, itchy scalp’ and advises them to carry out a patch test first to assess their sensitivity.

Comment

Maria Halasz, CEO of Cellmid commented on the clinical trial results, saying “In addition to the hair count and hair loss measurements the photographs taken during the PhotoGrammetrix™ evaluation demonstrate visible improvement in overall hair quality and volume… As this product has active ingredients subject to Cellmid’s recently filed patent application, the results give us multiple opportunities to commercialise this valuable asset.

Darren Jones, Head of Product Development at Cellmid, added, “These are very exciting and valuable results expected to support stronger clinical hair growth claims of this proprietary product. FGF5 is well recognised as the ultimate controller of hair loss. We are excited to be the first on the market with a clinically validated product range addressing FGF5” he added.

Leonora Doclis, Senior Trichologist at The Belgravia Centre said, “The exploration of FGF5 inhibitors is an innovative approach to developing new hair loss treatments and the results of évolis’ in vitro tests suggest this could be an exciting area to explore. However, as these tests were carried out on a fairly small scale, it would be interesting to see wider-ranging research carried out into the efficacy of these tonics used both on their own and in conjunction with other existing hair loss treatments like minoxidil. As the évolis formula comprises four botanical ingredients it may prove a good, natural hair growth booster to use alongside medically-proven hair loss treatments”.

Ingredients

évolis tonic for Men: Purified water, ethanol, butylene glycol, ginkgo biloba extract, eriobotrya japonica leaf extract, panthenyl ethyl ether, swertia chirata extract, glycyrrhetinic acid, citric acid, sodium citrate, maltodextrin

évolis tonic for Women: Purified water, ethanol, butylene glycol, poterium officinale root extract, rosa multiflora fruit extract, panthenyl ethyl ether, swertia chirata extract, glycyrrhetinic acid, citric acid, sodium citrate, maltodextrin

Share this article

MHRA Medical License  X  |   FDA Approval  X  |   Food Supplement  X

Mibelle Biochemistry believes a basil extract may hold the key to combating genetic hair loss. The Basilicum extract features in the company’s newly launched RootBioTec HO product which is a cosmetic formula designed to be used in hair oils, serums and conditioners as well as in anti-ageing haircare products.

This new basil extract ‘cosmetic active’ product is said to stimulate hair papilla cells and reduce hair loss. The company also claims RootBioTech HO gives ‘fuller hair’ and ‘rejuvenates [the] scalp’.

Speaking to Cosmetics Design Europe, the Head of Research for Mibelle Biochemistry, Dr. Daniel Schmid, explained, “It strongly inhibits the activity of 5 alpha reductase II – the enzyme that promotes the conversion of testosterone to DHT, ultimately stimulating demal papilla cells and helps renew hair activity in those that suffer from androgenic alopecia“.

Androgenic alopecia – more commonly known as Male Pattern Baldness or Female Pattern Hair Loss – occurs when people have an hereditary sensitivity to dihydrotestosterone (‘DHT’) – the hormone that causes this type of hair loss.

If left untreated, DHT will bind to the hair follicles around the top of the head in those with a genetic predisposition, weakening them until the hair gradually thins and sheds. RootBioTec HO is hoping to address this by preventing the formation of DHT, reducing hair loss boosting regrowth.

Product claims and study findings

Studies into this new hair loss product were carried out by its manufacturer, Mibelle Biochemistry. Details of the study findings are as follows:

Reducing hair loss:

Mibelle Biotech Chart showing Anti-Hair Loss Effect of RootBioTec HO

Mibelle Biotech Chart showing Anti-Hair Loss Effect of RootBioTec HO

According to the company’s marketing information, ‘The effect of RootBioTec HO against hair loss was evaluated on 19 women and 2 men aged between 25 and 67 years (average 51.1 years) suffering from mild to moderate hair loss (daily hair loss >100 strains)’.

This clinical trial lasted two months and required each of the volunteers to apply a fluid containing one per cent RootBioTec HO directly to their scalps, once every evening.

Results were measured at the end of month one and the end of month two. This was done by asking the volunteers to collect the hair they lost from combing every morning, then counting it. The study notes that ‘For the analysis the average was taken from total counts made on three consecutive days’.

The findings showed that the number of lost hairs dropped by 26 per cent after one month and reduced by 31 per cent after two months of using RootBioTec HO. On this basis the manufacturer claims its product ‘significantly reduces hair loss and thus leads to denser hair’.

Mibelle Biotech Graph showing Concentration of Basilicum Extract

Mibelle Biotech Graph Showing Concentration of Basilicum Extract Against Inhibition of 5a Reductase

Inhibiting DHT:

In order to investigate whether RootBioTec Basilicum extract could be a potent 5α reductase inhibitor, Mibelle states that it ‘was measured and compared to Finasteride’.

Details of how this was tested or who the product was tested on are not contained within the report, however, it is unlikely to be the same group of volunteers from the above mentioned study as finasteride 1mg is a male hair loss treatment and only two men were surveyed previously.

Mibelle says the results showed ‘a clear concentration dependent inhibition of 5α reductase II activity with an IC 50 value of 2.62 mg/ml. Consequently, RootBioTec HO might be able to reduce hair loss in people with androgenic alopecia’.

Hair growth boosting effects:

RootBio Tec’s literature talks about the dermal papilla cells ‘located within the hair follicle bulb’, advising that they are essential for hair growth.

Mibelle Biochemistry Diagram Explaining how RootBioTec HO Can Contribute to Increased Proliferation of Dermal Papilla Cells

Mibelle Biochemistry Diagram Explaining how RootBioTec HO Can Contribute to Increased Proliferation of Dermal Papilla Cells

It goes on to explain how multiplication of these dermal papilla cells was investigated, stating: ‘The effect of RootBioTec Basilicum extract on dermal papilla cell proliferation was investigated by the MTT assay.

Human dermal papilla cells were serum starved for 18 hours to stop cell proliferation and then treated with RootBioTec Basilicum extract during a period of 72 hours.’

Further noting that a positive control of cell proliferation of VEGF (vascular endothelial growth factor) was employed.

Providing a chart – pictured – showing the results, the information states that these showed that ‘RootBioTec HO can stimulate the dermal papilla cells to regain their proliferation capacity’.

Mibelle Biochemistry Chart comparing RootBioTec Basilicum extract to Finasteride

Mibelle Biochemistry Chart Comparing RootBioTec Basilicum Extract to Finasteride

Comment

Whilst RootBioTec HO certainly sounds like a positive addition to currently hair loss product offerings, the scale of the studies mentioned by the company is very small. In order to properly determine the product’s efficacy, we would like to see more research done on a larger scale, with clinical trials into all claims across an equal mix of men and women with similar levels of hair loss.

The fact that RootBioTec HO is listed as a cosmetic active means it would not be eligible for MHRA or FDA licensing given these regulators operate within the medical sector.

Current statistics show how effective their product is at boosting hair growth by comparing it to finasteride – a medication that is designed to inhibit DHT and treat male pattern hair loss when taken in 1mg doses. A more useful comparison would perhaps have been between RootBioTec and Minoxidil, a hair loss treatment for both men and women with hereditary hair loss, which is licensed by the MHRA and FDA for this purpose.

From the lists of ingredients, there is nothing included that has been proven to inhibit hereditary hair loss. Overall, RootBioTec HO seems to operate in a similar way to Azelaic Acid, a licensed medication which is added to some minoxidil formulations in order to boost the efficacy of this topical hair loss treatment.

RootBioTec ingredients

RootBioTec HO (Oil-based version): Ocimum Basilicum Hairy Root Culture Extract (and) Helianthus Annuus (Sunflower) Seed Oil (and) Cocos Nucifera (Coconut) Oil

RootBioTec HW (water-based version): Ocimum Basilicum Hairy Root Culture Extract (and) Alcohol (and) Aqua/Water

Related Stories


Share this article

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Amit

Question: I have seen various argan oil products advertised as hair loss treatments and saying that they will help to regrow hair – is this true? How do you use it? My hair is starting to recede at the front and go a bit thin on top so I want to find something to stop my hair falling out now before it gets too bad.

Answer: Hi Amit, thanks for your question. There is no medical evidence to support any claims that argan oil can treat hair loss. It cannot block the hormone (DHT) in your body which causes male pattern baldness and, therefore, argan oil is not a hair loss treatment.

Argan OilArgan oil is a natural, plant-derived cosmetic product that is used as an acne treatment as well as being a moisturiser for the hair and skin. Rich in vitamin E, which is known to be nourishing to the skin and can help heal scar tissue, the oil has become increasingly popular over the past few years. The current beauty industry craze for argan oil products has led to the government of Morocco – where the argan tree is most commonly found – planning to increase annual production from approximately 2,500 to 4,000 tonnes by 2020, to keep up with demand.

The marketing claims made by some argan oil hair care brands can be misleading. Whilst it will not cure or prevent balding, what the oil can do is improve the condition of your existing hair in the same way any good, deep conditioning treatment would. Having healthy, nourished hair may make it appear fuller and it is likely that this is where some of the ‘thickening’ and ‘hair loss cure’ claims stem from. What it will not do is prevent or block the cause of male hair loss, which means that – left untreated – the hair around the top of the head will continue to thin in those who are susceptible to this form of genetic hair loss.

As for how you use argan oil, as a conditioning treatment you would generally apply it in the same way you would any other hair conditioner. Once you have washed your hair, towel it dry so that it is damp rather than wet, then rub a few drops of the argan oil between your hands and run them through your hair to coat it with the oil. Leave this on for the recommended time stated on the product’s label – it is believed it can be beneficial to wrap the head in a towel (ideally a warm one) to help the oil penetrate the hair properly – before rinsing it out.

Some brands advise you massage your scalp with argan oil to stimulate it in order to promote hair growth. The logic behind this is, again, more cosmetic and to do with improving the condition of the skin and hair – it is nothing to do with treating hair loss and is highly unlikely to make your hair grow any quicker. It is, however, therapeutic in terms of being relaxing and helping to combat stress, which is good as stress can play a role in triggering or worsening hair loss.

Whilst massaging your scalp will help to improve the circulation of blood flow to the area – an essential factor for healthy hair – this has not been proven to boost hair growth or prevent hair loss. In fact, if you are not treating the root of the problem – the hereditary sensitivity to DHT – then increasing blood flow to the hair follicles will also help the DHT to circulate, which may make your hair loss worse!

There are only two medically-proven hair loss treatments for male pattern hair loss, both of which are licensed by the MHRA in the UK and the FDA in the USA. These are Propecia and minoxidil. Whilst using argan oil may improve the look of your existing hair, if you are concerned about signs of thinning you should speak to a hair loss expert who will be able to devise a personalised hair loss treatment plan tailored to your specific situation and stage of balding. You can find hundreds of examples showing the type of regrowth Belgravia clients have achieved through following specialised treatment programmes, in our Hair Loss Success Stories. 


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.

Share this article

Rogaine (known as ‘Regaine’ in the UK) has recently launched a new once-a-day foam treatment for female pattern hair loss with 5% minoxidil, in the United States. The new product has been introduced in addition to Rogaine’s existing product for women, which is a twice-per-day solution containing 2% Minoxidil.

Women's Rogaine Once Per Day FoamIs Minoxidil foam effective for treating hair loss?

According to reports from the manufacturer, clinical data showed that use of the product for 24 weeks results resulted in ‘some’ hair regrowth for 81% of the women who took part in the trial. However, it is not known what level of regrowth was achieved by these users or the stage of their hair loss when they started these trials.

Although the foam format of the product is designed to make it ‘fit into the regular beauty routine’ of the user, the evidence suggests this is probably less effective than a liquid product of the same strength. An ongoing Belgravia survey has discovered that men who have used the 5% liquid Regaine reported better results than those who have used Regaine 5% foam.

The reason for this may be to do with how effectively a foam is able to reach the scalp and soak into the skin. In order for a foam product to work as intended, it needs to be applied directly to the scalp to enable it to penetrate the skin. The directions for the Regaine foam products do instruct the user to massage it into the scalp, but it’s likely the hairloss product would also be absorbed into the hair by applying it in this way, meaning less of the foam gets to the affected areas.

Minoxidil as a hair loss treatment for women

Minoxidil is the only medically-proven treatment for genetic hair loss in women. It is medically licensed by the MHRA in the UK and approved by the equivalent body, the FDA in the USA.

Minoxidil encourages hair growth by reactivating dormant hair follicles. When applied to the scalp and absorbed into the scalp, minoxidil is converted into ‘minoxidil sulphite’, which is thought to activate potassium channels in cells, stimulating growth.

Whilst minoxidil has been seen to successfully reduce hereditary hair loss and boost hair growth for many, the degree of success will depend on the specific individual’s stage of hair loss and the duration of their condition before seeking professional assistance. If you are concerned about thinning hair or female hair loss it is best to seek expert advice as soon as possible.

Belgravia’s bespoke minoxidil

Female Pattern Hair Loss Patient Before and After PhotosBelgravia’s hair loss experts recommend personalised, comprehensive female hair loss treatment programmes featuring our bespoke minoxidil formulations, based on their diagnosis of your condition. Our exclusive minoxidil preparations feature MPG, Azelaic Acid and caffeine. These booster ingredients are particularly important as they can act as a substitute for the men-only hair loss medication, Propecia, by helping to block DHT – the hormone which causes pattern hair loss in those who are susceptible.

These treatment plans are designed specifically for each client and our patients – as well as many of their friends and families – are often amazed at the results they experience. You can find out more about our high strength minoxidil by calling us on 020 7730 6666.

There are many examples in our photographic Hair Loss Success Stories of clients who have used our treatments to fight female hair loss. These include Diane, pictured here, who said of her treatment, “Very happy and I can see results within the first year“. Click on the photos to view her Success Story in full.


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related stories:

 What's the difference between Belgravia Minoxidil and Women's Rogaine? Most Effective Treatments for Female Hair Loss Female Pattern Hair Loss
‘What’s The Difference Between Women’s Rogaine and Belgravia Minoxidil?’ Hair Loss in Women – Guide to Conditions and Treatments The Differences Between Male and Female Pattern Hair Loss
Share this article

New products designed to conceal hair loss are always being released, but the latest ‘KeraFiber’ powder promises to thicken the appearance of your hair instantly. Is this new craze just a flash in the pan, or does it provide real results for men and women affected by hair loss?

Kerafiber keratin hair fibre hair loss concealer product

Hair loss concealers such as KeraFiber mask, rather than treat, thinning hair

With eight million UK women with hair loss and a quarter of men affected by thinning hair by the time they are in their 30s, a product designed to conceal hair loss is sure to be in demand. KeraFiber is made from keratin, a protein naturally found in our skin, hair and nails. Statically charged fibres work by bonding to the user’s natural hair, for a secure hold. This thickens the appearance of the hair and can be set by using hairspray. The product is already proving popular with celebrity hair and make-up artists in the US and is now available in the UK.

Fibre hair loss concealers: nothing new

Fibre hair loss concealers are nothing new – Toppic and Couvre came out 30 years ago, and Nanogen previously released their ‘Nanofibres‘ product, which also uses microscopic keratin fibres to artificially add thickness and volume to hair. The fibres come in a pepper pot-style shaker which is applied to the scalp for a supposedly natural looking effect.

It is worth noting that keratin fibre concealers can only be used if you have some hair remaining on your scalp. They are not suitable for anyone who is completely bald and, if the underlying cause of your hair loss is not treated (as opposed to masked) your hair may continue to shed until these concealers no longer work.

Masking symptoms versus treating the cause

These keratin fibre concealers may be a ‘quick fix’ option for anyone looking to conceal hair loss or thinning hair, but remember they simply mask symptoms rather than treating the root cause of hair loss.

The average person sheds around 100 hairs a day, but if you have started to notice more hairs than usual in your brush or on your pillow, it’s time to see a professional hair loss expert who can diagnose the cause and prescribe a personalised hair loss treatment plan, if appropriate.

There are many different hair loss conditions, from genetic baldness, through to autoimmune conditions such as Alopecia, or lifestyle-related hair loss – many of which can be treated. The best treatment plan will vary according to what kind of hair loss you have and how advanced it is.


Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related stories:

Most Effective Treatments for Female Hair Loss How to Style Thinning Hair Whilst You Grow it Back Hair Loss Treatments for Men
FIND OUT ABOUT: Hair Loss Treatments for Women How to Style Thinning Hair Whilst You Grow It Back FIND OUT ABOUT: Hair Loss Treatments for Men
Share this article

Hot on the heels of the Theradome laser helmet which claims to reduce hair loss in women, comes the LaserCap.

What is the LaserCap?LaserCap - The Latest Wearable LLLT Hair Loss Treatment Device

The LaserCap is a flexible dome-shaped plastic membrane containing 224 low level lasers, which can be worn inside a cap or hat. Like the Theradome, it is designed to be a wearable solution to treating hair loss using low-level laser treatment (LLLT). LaserCap claims its portable, hands-free device will treat female and male hair loss, thinning, shedding and receding hair lines. The brand also describe the insert as ‘an anti-ageing treatment for the hair and scalp’.

Fits inside your own headwear

The LaserCap insert should be charged using the rechargeable battery pack provided, then worn inside your own headgear, or one of the caps provided with the device.

Once in place and turned on, the low-level lasers, which cover the top of the head, bathing it in red light, emit the therapeutic light which is used in all forms of LLLT and is scientifically-proven to boost hair regrowth.

The general guidance with regards to how long you should wear the LaserCap for, is to have three 20-minute sessions per week, and definitely no more than a 1 hour session every other day. However, the brand notes no formal tests have been carried out on use of the LaserCap beyond the 3 x 20 minute sessions. Users are directed to consult their doctor for specific advice on the timing best suited to them.

The main focus in the marketing of this insert, aside from the convenience angle, is that it uses ‘optimal power’. This means the LaserCap has been designed to deliver up to 4 Joules/cm2 of laser light energy to the scalp per treatment session. This is the power level shown to produce maximal cell activation in other LLLT devices.

Efficacy of the LaserCap

The LaserCap has not seemingly undergone any clinical trials yet as the double-blind LLLT study available from their website researches the efficacy and safety of a competitor’s low-level laser therapy device – the HairMax LaserComb.

The general science behind LLLT appears to be the main foundation for LaserCap’s claims that its treatment is ‘scientifically-proven’. Low-level laser light is clinically proven to promote hair growth. It does so by aiding respiration, micro-circulation, metabolism and protein synthesis at the cellular level and by increasing blood-flow to the scalp and hair follicles.

Developed in Ohio, USA, the LaserCap is not currently cleared for hair loss treatment by the FDA.

As hair transplant surgeon, Robert Haber, MD explains, ‘LaserCap uses the same laser diode wavelength and output power per laser as an FDA-cleared low-level-laser device for hair re-growth; however, LaserCap has 224 laser diodes versus 9 laser diodes in the FDA-cleared device and LaserCap treats the entire affected scalp with an accurate and adjustable light dosimetry’.

LaserCap states that the device is suitable for use with minoxidil and Propecia, and advise anyone taking male or female pattern hair loss treatments continue to use them in conjunction with their insert. This is because these are the only proven treatments for combatting hair loss. This information suggests – as we would expect – that the gadget is better suited to use as part of a pharmaceutical hair loss treatment plan, to boost the effects of established medications for stopping and reversing hair loss.

Other laser devices for treating hair loss

HairMax LaserComb Whilst the convenience of the LaserCap sounds promising, until further clinical trials have been carried out and FDA-clearance granted, hair loss sufferers may want to consider alternative options.

The recently-released Theradome was the first wearable LLLT device for hair loss treatment. Designed by a NASA scientist, the helmet has been cleared by the FDA for use by women and is pending approval for use by men. It has not yet been tested on either men or women with dark brown or black skin, however, this is also true of the HairMax LaserComb which has been found to work well on users with dark skin tones, despite a lack of studies.

The most popular laser therapy device is currently the award-winning HairMax LaserComb. Cleared by the FDA for use by men and women in treating hair loss, we recommend the LaserComb as part of a comprehensive hair loss treatment programme and include the device free of charge with most Belgravia plans. The LaserComb’s patented hair-dividing action allows the lasers to get straight to the scalp, rather than being stuck in the hair. We have found that using the HairMax LaserComb in conjunction with medically-proven hair loss treatments, helps to boost their effects and aids healthy hair regrowth.


The Belgravia Centre

The Belgravia Centre is the UK’s leading hair loss clinic, with two locations in Central London. If you are worried about hair loss you can arrange a free consultation or complete our online consultation form from anywhere in the UK or the rest of the world. View our extensive Hair Loss Success Stories gallery, which is the largest collection of ‘Before & After’ treatment pictures in the world, demonstrating the levels of success that so many of our patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related stories:

Low Level Laser Treatment - Does It Really Work? How Do Propecia and Minoxidil Treat Hair Loss? What Are Hair Regrowth Boosters?
How Do Minoxidil and Propecia Treat Hair Loss? Laser Hair Loss Treatment: Does It Really Work? What Are Hair Regrowth Boosters?
Share this article

An American company claims its new Theradome laser helmet is the first wearable laser scalp treatment to “stop hair loss, thicken existing hair and grow new hair”, but can this helmet really cure baldness?

Designed by a former NASA scientist, to be worn twice per week for 20 minutes at a time, the headgear is marketed more towards women with hair loss issues as, currently, the Theradome has only been FDA-cleared for use by women with their FDA clearance for men still pending

The cordless hair restoration device uses 80 cooling lasers that provide over 560 mW of low level laser therapy. This is meant to grow new, healthy hair whilst doubling the hair follicle size of existing hair, in addition to slowing down or stopping hair loss, with no side effects. Can this helmet cure baldness?

Theradome claims to show results over a period of over 100 weeks. After 18-24 weeks Theradome advises your hair will be ‘cleaner, more manageable…with improved lustre and fuller body’, with thicker, longer hair and a healthier scalp occurring after 26-50 weeks of continued use of the helmet. From 52 weeks they say you will start to see ‘the hairs on the top of the head and the vertex will start filling in’, then from the 100 week treatment mark onwards, Theradome claims users will experience ‘fuller and thicker hair will result with continued use’.

Two clinical trials were conducted by Theradome and their results state that the hair loss helmet was proven to regrow hair in 98% of users. Additionally, the studies found that hair thickness, volume and density increased by 200% within six weeks.

Our highly respected hair transplant partner, Dr Bessam Farjo, told the Daily Mail: ‘I do believe that laser technology has validity, but I’m sceptical of the specific claims made by Theradome GB that this particular headgear has the ability to increase the hair shaft diameter by 200 per cent. I have not seen any scientific evidence to support this.

‘It’s great to see businesses putting resources to the development of this technology, but more scientific results are needed to back-up the huge claims that Theradome is making.’

From the information available, this helmet appears to be potentially more of a hair growth booster rather than a hair loss treatment. Whilst hair growth boosters are an integral part of any full hair loss treatment programme, for optimum results they should be used alongside specialist medications developed to stop hair loss and start the regrowth process.

Theradome advises its helmet can be used alongside other hair loss treatments, stating that by doing so ‘your hair recovery will be even more rapid than just taking the pills alone.’

The laser therapy operates  in a similar way to the convenient HairMax LaserComb which, unlike the Theradome, is FDA-cleared for use by both men and women. A complimentary HairMax LaserComb can be included within most of Belgravia’s treatment courses.

These types of Hair Growth Boosters work primarily by stimulating the scalp to increase blood flow to the area, reducing inflammation of the scalp which can also help with scalp conditions such as dermatitis. This stimulus encourages hair growth, allowing the regrowth medication (usually Minoxidil) to work more effectively, whilst maintaining the condition of the hair and scalp.

If you would like our hair loss specialists to provide personal advice on the best course of treatment for your condition, call us on 020 7730 6666 or send us a message to book your free consultation. If you are unable to get to either of our Central London hair loss clinics, just complete our Online Diagnostic Form.

Share this article

MHRA Medical License X | FDA Approval X | Food Supplement Tick

MediGro is a product that is advertised as a treatment for hair loss. The product is a supplement, similar to a number of other hair supplements such as Procerin, Provillus and Hair Vitalics. None of these supplements are medications, and none have ingredients that are proven to assist in the prevention of hair loss.

MediGro contains a blend of ingredients (listed below) that has been titled the ‘GroMax’ blend by its manufacturers. Each of the ingredients contained are natural, supplemental products.

MediGroClinical efficacy (the effectiveness and safety of a product) is decided following large-scale clinical trials for medications. Medications that are clinically proven to carry out any medical purpose will be licensed by a medical regulatory body (if they are safe to use) such as the MHRA in the UK and the FDA in the USA. The only two medications that have been clinically proven to prevent hair loss and regrow hair, and are licensed by both the MHRA and FDA are minoxidil and Propecia. These two products were part of large-scale clinical trails on thousands of participants, and it was found that they did improve hair growth for men and women (Propecia men only) with genetic hair loss.

For more information on the medically proven treatments for hair loss and how to achieve the very best levels of hair regrowth please visit our Hair Loss Treatment page.

MediGro Ingredients

  • OptiMSM™
  • Horsetail
  • Kelp
  • L-arginine
  • Zinc
  • L-lysine
  • Biotin
  • Spirulina
Share this article

MHRA Medical License X | FDA Approval X | Food Supplement Tick

Hår Vokse is a supplement marketed for the prevention of hair loss. Like similar products Nourkrin and Viviscal, Har Vokse contains minerals and vitamins in addition to a marine protein extract from a ‘deep sea fish living along the Norwegian costline’.

Hår Vokse is an unlicensed product that claims on its website to have carried out a clinic study in 2001 that was published in the Journal of International Medical Research. Like any other unlicensed product, marketing for Har Vokse is not entitled to make claims of hair loss prevention or hair regrowth.

Har VokseThe Medicines and Healthcare Product Regulatory Agency (MHRA) and the Food and Drug Administration (FDA) are responsible for approving medicinal products in the UK and US respectively, and licensing them for a specific purpose once they have unequivocally demonstrated safety and efficacy in treating that condition. You can therefore only be
sure that a product is effective to its stated cause if it has been licensed by these bodies.

There are two products that have been licensed by both the UK and US medical regulatory bodies, these are Propecia and minoxidil. Both of these products are medically proven to prevent hair loss and regrow hair. Find out more about clinically proven hair loss treatments.

For more information on the most well known products that are marketed for hair loss, please visit our hair loss products page.

Har Vokse Ingredients

Natural Marine Protein Comlex™ – marine polysaccharides.
Amino acids
Zinc gluconate
Extracts of grape skin and grape seeds (antioxidants)
Vitamin B-complex
Vitamin E
Vitamin C
Chlorophyll

Share this article
31 Jul

Actor Alan Rickman Explains How Louis XIV Dealt With Hair Loss

Harry Potter actor Alan Rickman is no stranger to wearing wigs for a movie role: his most-famous hair-do – the one he sported when playing menacing Potions teacher Severus Snape – lifted off at the end of every day’s filming, and it’s thought that Rickman’s hair in Robin Hood: Prince Of Thieves was a wig, […]

Read full article »
30 Jul

‘What is Short Anagen Syndrome?’

Name: Patsy Question: What is Short Anagen Syndrome? I heard it has something to do with your hair not being able to grow properly? I really want to grow my hair long but it’s being really slow to grow so i want to know if I might have this. Thanks. Answer: Hi Patsy. Short Anagen Syndrome is a condition […]

Read full article »
30 Jul

Clinical Trial Studies Efficacy of PRP as a Hair Loss Treatment

A clinical trial at the University of Catalonia in Barcelona, hoping to ascertain whether platelet-rich plasma (PRP) is an effective treatment for people with genetic hair loss, is due for completion this month. PRP as a hair loss treatment Given it is the most prevalent cause of hairloss in the world – more commonly referred to as either Male […]

Read full article »